Vertex Pharmaceuticals (VRTX) Non Operating Interest Expenses (2009 - 2025)
Vertex Pharmaceuticals (VRTX) posted Non Operating Interest Expenses of $3.3 million for Q4 2025, little changed on a QoQ basis from $3.3 million in Q3 2025, and up 17.86% year-over-year from $2.8 million in Q4 2024.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Non Operating Interest Expenses (2009 - 2025) Analysis & Trends
Vertex Pharmaceuticals has reported Non Operating Interest Expenses for 10 years, with the latest figure at $3.3 million in Q4 2025.
- On a quarterly basis, Non Operating Interest Expenses rose 17.86% year-over-year to $3.3 million in Q4 2025; TTM through Dec 2025 was $13.3 million, a 56.54% decrease from a year earlier, with the FY2025 full-year figure at $13.3 million, down 56.54% from the prior year.
- Non Operating Interest Expenses was $3.3 million for Q4 2025 at Vertex Pharmaceuticals, roughly flat from $3.3 million in the prior quarter.
- The five-year high for Non Operating Interest Expenses was $11.2 million in Q2 2023, with the low at $2.8 million in Q4 2024.
- Average Non Operating Interest Expenses over 3 years is $7.0 million, with a median of $7.5 million recorded in 2024.
- The sharpest annual moves came in 2024 and 2025: Non Operating Interest Expenses slumped 73.58% in 2024, then climbed 17.86% in 2025.
- Over 3 years, Non Operating Interest Expenses stood at $10.6 million in 2023, then plunged by 73.58% to $2.8 million in 2024, then advanced by 17.86% to $3.3 million in 2025.
- The last three Non Operating Interest Expenses figures came in at $3.3 million (Q4 2025), $3.3 million (Q3 2025), and $3.7 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | - |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | - |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 3.30 Mn |
| Sep 30, 2025 | 3.30 Mn |
| Jun 30, 2025 | 3.70 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 7.50 Mn |
| Jun 30, 2024 | 9.90 Mn |
| Mar 31, 2024 | 10.40 Mn |
| Dec 31, 2023 | 10.60 Mn |
| Sep 30, 2023 | 10.90 Mn |
| Jun 30, 2023 | 11.20 Mn |
| Dec 31, 2020 | 16.29 Mn |
| Sep 30, 2020 | 13.86 Mn |
| Jun 30, 2020 | 13.87 Mn |
| Mar 31, 2020 | 14.14 Mn |
| Dec 31, 2019 | 14.25 Mn |
| Sep 30, 2019 | 14.55 Mn |
| Jun 30, 2019 | 14.84 Mn |
| Mar 31, 2019 | 14.87 Mn |
| Dec 31, 2018 | 18.74 Mn |
API Access
Vertex Pharmaceuticals Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();